To view this, you need to install the Flash Player 8. Please go to here and download it.
Individuals have every right to expect that the medication they take has been properly manufactured and labeled. Drug companies are required to print warnings labels on their products listing any complications that could arise from their use. However, defective drugs may put some people at extra risk for serious harm or even death. A defective drug is one whose positive health benefits are outweighed by negative side effects. Manufacturers may be unaware of the full extent of side effects, or they may issue inadequate warnings despite knowing the severity of potential outcomes. Either way, drug companies can be held accountable. If you’ve been harmed by any of the following medications/products, you may be entitled to financial compensation.
The Food and Drug Administration has issued two important warnings in the past several years regarding Paxil®. A December 2005 advisory warned that taking Paxil® during the first three months of pregnancy can double the risk of birth defects . In addition, a May 2006 study found that Paxil® can increase suicidal behavior, particularly in young adults. An earlier British study in 2003 warned that children who take Paxil® are 1.5 to 3.2 times more likely to engage in suicidal thoughts or attempts than those who do not take the drug.
In 2005, the FDA cited GlaxoSmithKline, the manufacturer of Paxil®, for failing to meet product quality and safety standards. In October 2006, Paxil® pills were recalled over concerns that they were missing a key active ingredient. Individuals who take these defective pills may experience severe withdrawal symptoms including suicidal thoughts, shooting pain, and flu-like symptoms.
If you or someone you love has taken Paxil® and suffered as a result, contact us today. We can help you obtain financial compensation.
Ortho Evra® was the first birth control patch approved by the FDA. The contraceptive only needs to be applied once a week; as a result, some women prefer it over the daily birth control pill. However, a September 2006 FDA safety alert warned that taking Ortho Evra® could double a woman’s risk of developing a severe blood clot. The patch contains 60 percent more estrogen than most birth control pills, which typically contain 35 micrograms of estrogen. High estrogen levels can significantly increase the likelihood that an individual will develop a blood clot. If you take Ortho Evra® and have suffered a severe blood clot, contact Blount & Blount today. Our lawyers can help you.
Serious concerns about the safety of Tequin® led to its discontinuation in May 2006. The drug was used to treat lung, sinus, and urinary infections as well as some sexually transmitted diseases. The FDA issued a warning about the drug in February 2006. Then a March 2006 report in the New England Journal of Medicine confirmed that alarming rates of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) were found in those individuals who used Tequin®. Compared to those who did not take the drug, Tequin® users were four times more likely to develop low blood sugar and 17 times more likely to develop high blood sugar. Symptoms vary between the two conditions, but serious complications can result including seizures and death. If you or a loved one has developed a blood sugar condition as a result of using Tequin®, contact Blount & Blount today. Our experienced attorneys can make sure you receive proper compensation for damages.
Ketek® is used to treat conditions such as chronic bronchitis and pneumonia. The FDA warns that Ketek® can cause severe liver damage for some individuals. Four people died from liver complications linked to the drug. If you have sustained liver damage from the use of Ketek®, contact Blount & Blount today. Our experienced dangerous drug attorneys can help you obtain compensation for your physical and emotional suffering.
On January 10, 2007, the FDA issued a Class 1 recall for certain lot numbers of the following Bard® Composix® Kugel® mesh hernia patches:
-Large Oval, 5.4” x 7.0”
-Large Circle, 4.5”
An FDA Class 1 recall targets defective products that pose the greatest threats, including serious injury and death, to consumers. The recalled Bard® Composix® Kugel® patches have a defective “memory recoil ring” that can break off once the patch is implanted inside the body. Serious medical complications can ensue. Your surgeon should contact you if a recalled patch was used in your procedure. Please seek medical attention immediately if you experience abdominal pain, tenderness at the implant site, fever, or other symptoms at any point after the procedure. If a faulty Bard® Composix® Kugel® patch was used in your surgery and you have suffered as a result, please contact Blount & Blount today. We can help you obtain financial compensation for your medical bills, as well as for any physical and emotional pain you have been forced to endure.
Blount & Blount, P.C.
1420 Suite A
East Arlington Blvd.
Greenville, NC 27858
Toll Free: 1.866.565.9946
Fax: 252.752.2174